{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:54:18Z","timestamp":1770990858160,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T00:00:00Z","timestamp":1667088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T00:00:00Z","timestamp":1667088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1038\/s41443-022-00627-8","type":"journal-article","created":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T10:03:45Z","timestamp":1667124225000},"page":"437-442","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Testosterone improved erectile function by upregulating transcriptional expression of growth factors in late androgen replacement therapy model rats"],"prefix":"10.1038","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9683-4680","authenticated-orcid":false,"given":"Tomoya","family":"Kataoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akimasa","family":"Sanagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Furukawa-Hibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,30]]},"reference":[{"key":"627_CR1","first-page":"3025","volume":"80","author":"T Mulligan","year":"1995","unstructured":"Mulligan T, Iranmanesh A, Gheorghiu S, Godschalk M, Veldhuis JD. Amplified nocturnal luteinizing hormone (LH) secretory burst frequency with selective attenuation of pulsatile (but not basal) testosterone secretion in healthy aged men: possible Leydig cell desensitization to endogenous LH signaling\u2013a clinical research center study. J Clin Endocrinol Metab. 1995;80:3025\u201331.","journal-title":"J Clin Endocrinol Metab"},{"key":"627_CR2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0022-5347(17)39975-5","volume":"143","author":"MG Bandyk","year":"1990","unstructured":"Bandyk MG, Sawczuk IS, Olsson CA, Katz AE, Buttyan R. Characterization of the products of a gene expressed during androgen-programmed cell death and their potential use as a marker of urogenital injury. J Urol. 1990;143:407\u201313.","journal-title":"J Urol"},{"key":"627_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41443-018-0056-0","volume":"31","author":"PK Kavoussi","year":"2019","unstructured":"Kavoussi PK, Smith RP, Oliver JL, Costabile RA, Steers WD, Brown-Steinke K, et al. S-nitrosylation of endothelial nitric oxide synthase impacts erectile function. Int J Impot Res. 2019;31:31\u20138.","journal-title":"Int J Impot Res"},{"key":"627_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/j.1939-4640.2005.tb01091.x","volume":"26","author":"AM Traish","year":"2005","unstructured":"Traish AM, Toselli P, Jeong SJ, Kim NN. Adipocyte accumulation in penile corpus cavernosum of the orchiectomized rabbit: a potential mechanism for veno-occlusive dysfunction in androgen deficiency. J Androl. 2005;26:242\u20138.","journal-title":"J Androl"},{"key":"627_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/j.1464-410X.2006.06268.x","volume":"98","author":"I Kovanecz","year":"2006","unstructured":"Kovanecz I, Ferrini MG, Vernet D, Nolazco G, Rajfer J, Gonzalez-Cadavid NF. Pioglitazone prevents corporal veno-occlusive dysfunction in a rat model of type 2 diabetes mellitus. BJU Int. 2006;98:116\u201324.","journal-title":"BJU Int"},{"key":"627_CR6","first-page":"33","volume":"5","author":"ZJ Shen","year":"2003","unstructured":"Shen ZJ, Zhou XL, Lu YL, Chen ZD. Effect of androgen deprivation on penile ultrastructure. Asian J Androl. 2003;5:33\u20136.","journal-title":"Asian J Androl"},{"key":"627_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/sj.ijir.3901006","volume":"15","author":"L Petrone","year":"2003","unstructured":"Petrone L, Mannucci E, Corona G, Bartolini M, Forti G, Giommi R, et al. Structured interview on erectile dysfunction (SIEDY): a new, multidimensional instrument for quantification of pathogenetic issues on erectile dysfunction. Int J Impot Res. 2003;15:210\u201320.","journal-title":"Int J Impot Res"},{"key":"627_CR8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jsxm.2019.11.270","volume":"17","author":"G Corona","year":"2020","unstructured":"Corona G, Torres LO, Maggi M. Testosterone therapy: what we have learned From trials. J Sex Med. 2020;17:447\u201360.","journal-title":"J Sex Med"},{"key":"627_CR9","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/bju.13438","volume":"117","author":"I Hwang","year":"2016","unstructured":"Hwang I, Lee HS, Yu HS, Kim ME, Lee JS, Park K. Testosterone modulates endothelial progenitor cells in rat corpus cavernosum. BJU Int. 2016;117:976\u201381.","journal-title":"BJU Int"},{"key":"627_CR10","doi-asserted-by":"publisher","first-page":"e2000","DOI":"10.7717\/peerj.2000","volume":"4","author":"R Li","year":"2016","unstructured":"Li R, Meng X, Zhang Y, Wang T, Yang J, Niu Y, et al. Testosterone improves erectile function through inhibition of reactive oxygen species generation in castrated rats. PeerJ 2016;4:e2000.","journal-title":"PeerJ"},{"key":"627_CR11","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.jsxm.2017.11.001","volume":"14","author":"T Kataoka","year":"2017","unstructured":"Kataoka T, Hotta Y, Maeda Y, Kimura K. Testosterone deficiency causes endothelial dysfunction via elevation of asymmetric dimethylarginine and oxidative stress in castrated rats. J Sex Med. 2017;14:1540\u20138.","journal-title":"J Sex Med"},{"key":"627_CR12","doi-asserted-by":"publisher","first-page":"100348","DOI":"10.1016\/j.esxm.2021.100348","volume":"9","author":"T Kataoka","year":"2021","unstructured":"Kataoka T, Hotta Y, Yamamoto Y, Fukamoto A, Takeuchi M, Maeda Y, et al. Effect of late androgen replacement therapy on erectile function Through structural changes in castrated rats. Sex Med. 2021;9:100348.","journal-title":"Sex Med"},{"key":"627_CR13","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.jsxm.2021.06.004","volume":"18","author":"T Kataoka","year":"2021","unstructured":"Kataoka T, Mori T, Suzuki J, Kawaki Y, Kito Y, Hotta Y, et al. Oxaliplatin, an anticancer agent, causes erectile dysfunction in rats due to endothelial dysfunction. J Sex Med. 2021;18:1337\u201345.","journal-title":"J Sex Med"},{"key":"627_CR14","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl. 2013;48:452\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"627_CR15","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/35025215","volume":"407","author":"GD Yancopoulos","year":"2000","unstructured":"Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242\u20138.","journal-title":"Nature"},{"key":"627_CR16","first-page":"5128","volume":"59","author":"YS Gho","year":"1999","unstructured":"Gho YS, Kleinman HK, Sosne G. Angiogenic activity of human soluble intercellular adhesion molecule-1. Cancer Res. 1999;59:5128\u201332.","journal-title":"Cancer Res"},{"key":"627_CR17","first-page":"2507","volume":"3","author":"IB Joseph","year":"1997","unstructured":"Joseph IB, Nelson JB, Denmeade SR, Isaacs JT. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue. Clin Cancer Res. 1997;3:2507\u201311.","journal-title":"Clin Cancer Res"},{"key":"627_CR18","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/S0022-5347(05)68994-X","volume":"161","author":"S H\u00e4ggstr\u00f6m","year":"1999","unstructured":"H\u00e4ggstr\u00f6m S, Lissbrant IF, Bergh A, Damber JE. Testosterone induces vascular endothelial growth factor synthesis in the ventral prostate in castrated rats. J Urol. 1999;161:1620\u20135.","journal-title":"J Urol"},{"key":"627_CR19","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/376517a0","volume":"376","author":"AE Koch","year":"1995","unstructured":"Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 1995;376:517\u20139.","journal-title":"Nature"},{"key":"627_CR20","doi-asserted-by":"publisher","first-page":"7614","DOI":"10.1074\/jbc.M009705200","volume":"276","author":"I Kim","year":"2001","unstructured":"Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem. 2001;276:7614\u201320.","journal-title":"J Biol Chem"},{"key":"627_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ceb.2014.04.011","volume":"29","author":"E Shvets","year":"2014","unstructured":"Shvets E, Ludwig A, Nichols BJ. News from the caves: update on the structure and function of caveolae. Curr Opin Cell Biol. 2014;29:99\u2013106.","journal-title":"Curr Opin Cell Biol"},{"key":"627_CR22","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1091\/mbc.e11-09-0811","volume":"23","author":"Z Chen","year":"2012","unstructured":"Chen Z, Bakhshi FR, Shajahan AN, Sharma T, Mao M, Trane A, et al. Nitric oxide-dependent Src activation and resultant caveolin-1 phosphorylation promote eNOS\/caveolin-1 binding and eNOS inhibition. Mol Biol Cell. 2012;23:1388\u201398.","journal-title":"Mol Biol Cell"},{"key":"627_CR23","doi-asserted-by":"publisher","first-page":"32363","DOI":"10.1074\/jbc.M003075200","volume":"275","author":"J Igarashi","year":"2000","unstructured":"Igarashi J, Michel T. Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae. eNOS activation by sphingosine 1-phosphate and the role of caveolin-1 in sphingolipid signal transduction. J Biol Chem. 2000;275:32363\u201370.","journal-title":"J Biol Chem"},{"key":"627_CR24","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.cmet.2008.07.008","volume":"8","author":"L Liu","year":"2008","unstructured":"Liu L, Brown D, McKee M, Lebrasseur NK, Yang D, Albrecht KH, et al. Deletion of Cavin\/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance. Cell Metab. 2008;8:310\u20137.","journal-title":"Cell Metab"},{"key":"627_CR25","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/ncb1887","volume":"11","author":"CG Hansen","year":"2009","unstructured":"Hansen CG, Bright NA, Howard G, Nichols BJ. SDPR induces membrane curvature and functions in the formation of caveolae. Nat Cell Biol. 2009;11:807\u201314.","journal-title":"Nat Cell Biol"},{"key":"627_CR26","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/emboj.2009.46","volume":"28","author":"KA McMahon","year":"2009","unstructured":"McMahon KA, Zajicek H, Li WP, Peyton MJ, Minna JD, Hernandez VJ, et al. SRBC\/cavin-3 is a caveolin adapter protein that regulates caveolae function. EMBO J. 2009;28:1001\u201315.","journal-title":"EMBO J"},{"key":"627_CR27","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00441-017-2587-y","volume":"368","author":"B Zhu","year":"2017","unstructured":"Zhu B, Sw\u00e4rd K, Ekman M, Uvelius B, Rippe C. Cavin-3 (PRKCDBP) deficiency reduces the density of caveolae in smooth muscle. Cell Tissue Res. 2017;368:591\u2013602.","journal-title":"Cell Tissue Res"},{"key":"627_CR28","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/cvr\/cvy297","volume":"115","author":"R Suades","year":"2019","unstructured":"Suades R, Cosentino F. Sirtuin 1\/soluble guanylyl cyclase: a nitric oxide-independent pathway to rescue ageing-induced vascular dysfunction. Cardiovasc Res. 2019;115:485\u20137.","journal-title":"Cardiovasc Res"},{"key":"627_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/1440-1681.12362","volume":"42","author":"U Kilic","year":"2015","unstructured":"Kilic U, Gok O, Elibol-Can B, Uysal O, Bacaksiz A. Efficacy of statins on sirtuin 1 and endothelial nitric oxide synthase expression: the role of sirtuin 1 gene variants in human coronary atherosclerosis. Clin Exp Pharm Physiol. 2015;42:321\u201330.","journal-title":"Clin Exp Pharm Physiol"},{"key":"627_CR30","doi-asserted-by":"publisher","first-page":"31780","DOI":"10.1074\/jbc.M104353200","volume":"276","author":"T Kimura","year":"2001","unstructured":"Kimura T, Sato K, Kuwabara A, Tomura H, Ishiwara M, Kobayashi I, et al. Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells. J Biol Chem. 2001;276:31780\u20135.","journal-title":"J Biol Chem"},{"key":"627_CR31","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1172\/JCI200418004","volume":"113","author":"JR Nofer","year":"2004","unstructured":"Nofer JR, van der Giet M, T\u00f6lle M, Wolinska I, von Wnuck Lipinski K, Baba HA, et al. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest. 2004;113:569\u201381.","journal-title":"J Clin Invest"},{"key":"627_CR32","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1161\/CIRCULATIONAHA.105.607135","volume":"114","author":"G Theilmeier","year":"2006","unstructured":"Theilmeier G, Schmidt C, Herrmann J, Keul P, Sch\u00e4fers M, Herrgott I, et al. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia\/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation 2006;114:1403\u20139.","journal-title":"Circulation"},{"key":"627_CR33","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0092-8674(00)81661-X","volume":"99","author":"MJ Lee","year":"1999","unstructured":"Lee MJ, Thangada S, Claffey KP, Ancellin N, Liu CH, Kluk M, et al. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 1999;99:301\u201312.","journal-title":"Cell"},{"key":"627_CR34","doi-asserted-by":"publisher","first-page":"10664","DOI":"10.1073\/pnas.1934494100","volume":"100","author":"J Igarashi","year":"2003","unstructured":"Igarashi J, Erwin PA, Dantas AP, Chen H, Michel T. VEGF induces S1P1 receptors in endothelial cells: implications for cross-talk between sphingolipid and growth factor receptors. Proc Natl Acad Sci USA. 2003;100:10664\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"627_CR35","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.eururo.2004.10.021","volume":"47","author":"XH Zhang","year":"2005","unstructured":"Zhang XH, Morelli A, Luconi M, Vignozzi L, Filippi S, Marini M, et al. Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum. Eur Urol. 2005;47:409\u201316.","journal-title":"Eur Urol"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41443-022-00627-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-022-00627-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-022-00627-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T12:03:34Z","timestamp":1716811414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-022-00627-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,30]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["627"],"URL":"https:\/\/doi.org\/10.1038\/s41443-022-00627-8","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,30]]},"assertion":[{"value":"14 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}